#1Advancing Animal Health Zoetis Investor Presentation 253 zoetis#2Zoetis at a Glance 70 Years of experience 100+ Countries with market presence 2 $7.8B Annual revenue 8 Core animal species 7 Major product categories 61% Revenue from companion animal products 28 Manufacturing sites 1 39% Revenue from livestock products Note: Facts and figures shown are as of Dec. 31, 2021 ¹Excludes revenue associated with Client Supply Services and Human Health, which represented 1% of total 2021 revenue. 1,300 Approximate R&D colleagues 12,100 Approximate colleagues worldwide 3,800 Approximate field force members MAPOD We provide: Medicines Vaccines Diagnostics Genetic tests Biodevices Precision animal health zoetis#3Our Executive Team 3 Kristin Peck Chief Executive Officer Nick Ashton Executive Vice President and President, Global Manufacturing and Supply Wetteny Joseph Executive Vice President and Chief Financial Officer Tim Bettington Executive Vice President and President, U.S. Operations and Global Customer Experience Roxanne Lagano Executive Vice President, Chief Human Resources Officer and Global Operations Heidi Chen Executive Vice President, General Counsel & Corporate Secretary; Business Lead of Human Health Diagnostics Wafaa Mamilli Executive Vice President, President and Chief Information and Digital Officer (CIDO) Glenn David Executive Vice President and Group President, International Operations, Aquaculture, Bio Devices and Pet Insurance. Abhay Nayak Executive Vice President, Head of Strategy, Accelerated Growth Businesses and Commercial Development Jeannette Ferran Astorga Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer Rob Polzer Executive Vice President and President, Research and Development zoetis#4#5#6#7#8#9#10#11#12#13#14#15#16#17